Walmart’s latest brand and logo update has left some social media ... One poked fun at the new design by posting a screenshot from “The Office” of Jenna Fischer’s character Pam saying ...

Instead, Walmart gave its logo a makeover fit for modern times ... the W in lowercase), with the now-familiar yellow spark design at the end. Bruno Benedini is the founder of Taillight, a ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

Not all reactions to the not-so-new logo were negative. Some design and marketing websites ... There was likely a professional team behind the update, even if the changes appear minor.

Hockey fans applaud as Greensboro Gargoyles is unveiled as the name of the new Greensboro professional hockey club on Tuesday at Piedmont Hall. The formal revelation of the name and logo came in a ...

A team that includes the University of Washington's David Baker, who picked up his Nobel in Stockholm last month, used software tools to design completely new proteins that are able to inhibit ...

Here are some before and after pictures of the company's wordmark and logo. Need a break? Play the USA TODAY Daily Crossword Puzzle. Here's a look at how the new wordmark and logo will appear on ...

Walmart is refreshing its logo for the first time in nearly two decades, highlighting its evolution while also serving as a nod to its past, the big-box retailer announced Monday. The word mark on ...

While, on the surface, Walmart’s new logo may appear a minor change that anyone could have done, there’s likely to be a dedicated and professional team behind it. With figures suggesting ...

In a report released today, Ryan Deschner from Raymond James maintained a Buy rating on ARS Pharmaceuticals (SPRY – Research Report), with a price target of $28.00. The company’s shares closed ...

Raymond James raised the firm’s price target on ARS Pharmaceuticals (SPRY) to $28 from $26 and keeps a Strong Buy rating on the shares. ARS Pharmaceuticals pre-announced Q4 net sales of $6.5M ...